No. At this time, companies are not allowed to make a generic Bydureon as the drug is protected by patents. The first patent is set to expire in December 2016 -- this would be the earliest predictable date that a generic version could become available. However, many circumstances could affect when generic versions are actually allowed.
- Bydureon Information for Consumers
- Bydureon Information for Healthcare Professionals (includes dosage details)
- Side Effects of Bydureon (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 8 Apr 2013 • 2 answers
Posted 28 Feb 2014 • 1 answer
Posted 20 Jan 2016 • 2 answers
Posted 13 Apr 2016 • 0 answers
Posted 17 Dec 2017 • 0 answers